← Open Payments lookup

MARY HORSEMAN: Open Payments

NPI 1598778680 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$900 in 40 payments from 14 companies in 2025. Trend: 2023 $467 · 2024 $1,085 · 2025 $900

Food & beverage: $900
CompanyPaymentsAmount
Janssen Biotech, Inc.6$187
ABBVIE INC.5$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$80
Takeda Pharmaceuticals U.S.A., Inc.4$75
PFIZER INC.4$68
Intercept Pharmaceuticals, Inc.3$68
GENZYME CORPORATION2$60
Gilead Sciences, Inc.2$44
QOL Medical, LLC2$43
Celltrion USA Inc.2$39

Products named: TREMFYA, XIFAXAN, VELSIPITY, OCALIVA, CREON, DUPIXENT, ENTYVIO, Sucraid.

Industry payments across MD — which companies pay providers there.